Century Therapeutics, Inc.

The momentum for this stock is not very good. Century Therapeutics, Inc. is not a good growth stock. Century Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Century Therapeutics, Inc..
Log in to see more information.

News

Century Therapeutics (NASDAQ:IPSC) Trading 5.5% Higher
Century Therapeutics (NASDAQ:IPSC) Trading 5.5% Higher

Zolmax Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) traded up 5.5% during trading on Monday . The company traded as high as $1.61 and last traded at $1.54. 269,398 shares changed hands during...\n more…

Century Therapeutics (NASDAQ:IPSC) Shares Up 5.5%
Century Therapeutics (NASDAQ:IPSC) Shares Up 5.5%

Ticker Report Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) shares traded up 5.5% during mid-day trading on Monday . The stock traded as high as $1.61 and last traded at $1.54. 269,398 shares were...\n more…

HC Wainwright Comments on Century Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:IPSC)
HC Wainwright Comments on Century Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:IPSC)

Ticker Report Century Therapeutics, Inc. (NASDAQ:IPSC - Free Report) - HC Wainwright upped their Q3 2024 EPS estimates for Century Therapeutics in a report issued on Thursday, August 15th. HC Wainwright analyst M...\n more…

Vanguard Group Inc. Raises Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC)
Vanguard Group Inc. Raises Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC)

Ticker Report Vanguard Group Inc. raised its position in Century Therapeutics, Inc. (NASDAQ:IPSC - Free Report) by 1.2% during the first quarter, according to the company in its most recent 13F filing with the...\n more…

Century Therapeutics (NASDAQ:IPSC) Price Target Cut to $9.00
Century Therapeutics (NASDAQ:IPSC) Price Target Cut to $9.00

Zolmax Century Therapeutics (NASDAQ:IPSC - Get Free Report) had its target price cut by stock analysts at HC Wainwright from $11.00 to $9.00 in a research report issued on Thursday, Benzinga reports. The...\n more…

Century Therapeutics price target lowered by $2 at H.C. Wainwright, here's why
Century Therapeutics price target lowered by $2 at H.C. Wainwright, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…